Metabolic Syndrome
📧 Sign up to get email alerts when something new happens for Metabolic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-15Clinical Trial Update: Isoleucine Addition Treatment Effects in a Controlled Diet Study [NA]
A clinical trial evaluating the addition of the amino acid isoleucine to a controlled diet for individuals with prediabetes and metabolic sy…
-
CLINICAL_TRIALS withdrawal · 2025-06-13Clinical Trial Update: Hangzhou Hospital Staff Cohort
A clinical trial involving Hangzhou Hospital staff has been withdrawn; the sponsor is Westlake University and the trial concerned diabetes m…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control [NA]
The clinical trial evaluating brisk walking and regular-intensity exercise for glycemic control in metabolic syndrome and obesity has been w…
-
CLINICAL_TRIALS withdrawal · 2024-10-04Clinical Trial Update: Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome [Phase 3]
A Phase 3 trial evaluating metformin for prevention and intervention of metabolic syndrome in patients initiating androgen deprivation thera…
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Effect of Very Low Carbohydrate Diet on Glycemic, Metabolic, Glycated and Inflammatory Markers in Gestational Diabetes Mellitus [NA]
The clinical trial evaluating a very low carbohydrate diet for gestational diabetes mellitus and related metabolic and inflammatory markers …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Regression of Fatty Heart by Valsartan Therapy [Phase 4]
A Phase 4 trial evaluating valsartan for regression of fatty heart in metabolic syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-18Clinical Trial Update: Protandim and the Metabolic Syndrome [NA]
The clinical trial NCT01125501 evaluating Protandim for metabolic syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Magnetic Resonance Imaging-Portfolio Diet Study #7 [NA]
This document reports the withdrawal of Clinical Trial Update: Magnetic Resonance Imaging-Portfolio Diet Study #7, sponsored by Unity Health…
-
CLINICAL_TRIALS withdrawal · 2017-02-14Clinical Trial Update: Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial [NA]
This clinical trial evaluating a promotora-based intervention for metabolic syndrome in rural adult Hispanics has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)
An observational trial evaluating fenofibrate (Lipilfen Capsule) for the incidence of major adverse cardiovascular events and safety in meta…
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Effect of Lycopene and Isoflavones on Glucose Metabolism [NA]
The clinical trial investigating the effects of lycopene and isoflavones on glucose metabolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Hispanics With Metabolic Syndrome and Non-ischemic Heart Failure
The clinical trial NCT00804882 investigating Hispanics with metabolic syndrome and non-ischemic heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-04Clinical Trial Update: Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome [Phase 2]
A Phase 2 trial evaluating the metabolic effects of resveratrol in insulin resistance/metabolic syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-31Clinical Trial Update: Characterization of Beta Cell Failure [NA]
The clinical trial 'Characterization of Beta Cell Failure' (NCT00869102) sponsored by University Hospital Tuebingen has been withdrawn. The …
-
CLINICAL_TRIALS withdrawal · 2013-11-18Clinical Trial Update: The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Phase 1]
Phase 1 clinical trial of dual RAAS blockade with valsartan and aliskiren in African American patients with hypertension and metabolic syndr…
-
CLINICAL_TRIALS withdrawal · 2013-02-20Clinical Trial Update: Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. [NA]
A clinical trial evaluating low-dose growth hormone treatment for metabolic syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2008-12-05Clinical Trial Update: Testosterone Effects on Men With the Metabolic Syndrome [Phase 2]
A Phase 2 trial evaluating the effects of testosterone in men with metabolic syndrome has been withdrawn.